ESR1 and breast cancer: While CHK2 depletion did not change the proliferation of ERα-positive BC cell lines in both high-throughput screens, CHK1 depletion induced by CRISPR/CAS9- or siRNA-mediated experiments reduced the cell viability of ERα-positive BC cell lines (Fig. 2E and F).